Cumanda is very effective in treating the Borrelia burgdorferi bacteria, and practitioners are now using it in conjunction with Samento to treat Lyme borrelisosis. Lyme borreliosis has been linked to hundreds of medical conditions; many researchers and physicians believe that Lyme borreliosis may be a factor in most chronic conditions.
One of the most impressive benefits of Cumanda is its antifungal action. Physicians report that it is effective in treating many difficult to treat fungi including Mycosis fungoides, Candida krusei, Candida albicans and Aspergillus niger, to name a few.
In May 2005, pharmacological studies were conducted in laboratory rodents at the University of Guayaquil in Ecuador. In an anti-inflammatory effect study the Nutramedix Cumanda inhibited inflammation by 97%. It was compared with Pfizer’s best selling and very toxic anti-inflammatory drug, Feldene (PIROXICAM), which inhibited inflammation by 98%.